Irbesartan Tablet
Product Images NDC 63187-737

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 63187-737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1-2 (Figure 1 2)

Figure-1-2 (Figure 1 2)
Two graphs showing placebo-subtracted reductions in trough systolic and diastolic blood pressure (SeSBP and SeDBP) in mmHg versus irbesartan dose in mg/day. The left graph (Figure 1) depicts SeSBP reduction with dose, and the right graph (Figure 2) depicts SeDBP reduction with dose, both labeled as integrated analyses.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A Kaplan-Meier curve chart showing cumulative event rates over months of follow-up. The graph compares primary endpoints (doubling of serum creatinine, end-stage renal disease, or all-cause mortality) among patients treated with Irbesartan, Amlodipine, and placebo. Lines representing each group indicate event progression over time with accompanying statistical values for hazard ratio and p-values comparing Irbesartan to placebo and Amlodipine.*
FDA Label Image

63187-737-30 (Irbesartan 150mg 30s)

63187-737-30 (Irbesartan 150mg 30s)
Label for Irbesartan 150 mg tablets by Proficient Rx LP, NDC 63187-737-30. The label states the product contains 30 film-coated tablets, each with 150 mg Irbesartan USP. It includes manufacturer information for Macleods Pharmaceuticals Ltd, Daman, India, storage recommendations, and a QR code.*
FDA Label Image

Irbesartan (Irbesartan)

Irbesartan (Irbesartan)
Chemical structure of Irbesartan, depicting its molecular framework with characteristic ring systems and side chains consistent with the angiotensin II receptor antagonist.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.